市場調查報告書

大腸內視鏡檢驗前治療藥的全球市場:市場規模、佔有率、預測、機會分析 - 各醫藥品類型、流通管道

Colonoscopy Bowel Preparation Drugs Market: by Drug Type, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

出版商 Coherent Market Insights 商品編碼 931880
出版日期 內容資訊 英文 173 Pages
商品交期: 2-3個工作天內
價格
大腸內視鏡檢驗前治療藥的全球市場:市場規模、佔有率、預測、機會分析 - 各醫藥品類型、流通管道 Colonoscopy Bowel Preparation Drugs Market: by Drug Type, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
出版日期: 2020年03月12日內容資訊: 英文 173 Pages
簡介

大腸內視鏡檢驗前治療藥,在大腸癌症的篩檢、檢驗中用於清洗大腸。所使用的醫藥品,分類為等滲透壓劑,高滲透壓劑,低滲透壓劑,並用劑。低滲透壓劑,包含稱為PEG-3350(PEG-SD)的少量PEG製劑,需要供給電解質溶液(運動飲料),與bisacodyl並用。

本報告提供全球大腸內視鏡檢驗前治療藥市場調查,市場概要,各醫藥品類型、流通管道、地區的市場規模的變化與預測,市場成長要素及阻礙因素分析,市場機會,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 調查目的與假設

  • 調查目的
  • 假設
  • 簡稱

第2章 市場展望

  • 報告概要
    • 市場定義和範圍
  • 摘要整理
    • 市場片段:各醫藥品類型
    • 市場片段:各流通管道
    • 市場片段:各地區
  • Coherent Opportunity Map(COM)

第3章 市場動態、規定、趨勢分析

  • 市場動態
  • 成長要素
  • 阻礙因素
  • 市場機會
  • 影響分析
  • 償付方案
  • 流行病學
  • PEST分析
  • 產品的上市
  • 合併、收購方案

第4章 全球大腸內視鏡檢驗前治療藥市場:各醫藥品類型

  • 簡介
  • 等滲透壓劑
  • 低滲透壓劑
  • 高滲透壓劑
  • 組合藥物

第5章 全球大腸內視鏡檢驗前治療藥市場:各流通管道

  • 簡介
  • 醫院藥局
  • 零售藥局
  • 其他

第6章 全球大腸內視鏡檢驗前治療藥市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東
  • 非洲

第7章 競爭情形

  • 熱圖分析
  • 市場佔有率分析
    • Ferring B.V.
    • Bayer AG
    • Braintree
    • Bausch Health Companies Inc.
    • Norgine B.V.
  • 分析師的見解

第8章 Section

  • 參考資料
  • 調查手法
  • 關於Coherant Market Insights
目錄

Colonoscopy bowel preparation drugs are used in cleansing the colon for screening and detection of colorectal cancer. The drugs to be used for cleansing colon is classified as isosmotic agents, hyperosmotic agents, hyposmotic agents, and combination agents. The hyposmotic agents include a low-volume PEG preparation called PEG-3350 (PEG-SD) that requires an additional electrolyte solution (sports drink) and often combined with bisacodyl.

Market Dynamics

The increasing prevalence of colon cancer is expected to propel global demand for colonoscopy bowel preparation drugs over the forecast period. For instance, according to the Global Cancer (GLOBOCAN) statistics published in January 2020, in the U.S., annually, around 147,950 new cases of large bowel cancer are diagnosed, of which around 104,610 cases are of colon cancer and the remaining are rectal cancer.

The increasing adoption of strategies such as collaborations and acquisitions by the market players is expected to drive the market growth over the forecast period. For instance, in May 2018, Sebela Pharmaceuticals, a specialty pharmaceutical company, acquired Braintree Laboratories Inc., a prescription pharmaceuticals manufacturing company, for expanding its gastroenterology product portfolio. For instance, in January 2020, Norgine B.V. entered into an exclusive license and distribution agreement with Aspen Pharmacare, a South African pharmaceutical holding company, for distribution and commercialization of PLENVU in the Republic of Southern Africa, Lesotho, Eswatini, Botswana, and Namibia.

Moreover, rising product launches by the market players is expected to propel the market growth over the forecast period. For instance, in February 2018, Ferring Pharmaceuticals launched Clenpiq, the first ready-to-drink colonoscopy preparation. Clenpiq contains stimulant laxative sodium picosulfate, and magnesium oxide and anhydrous citric acid, which forms the osmotic laxative magnesium citrate.

Key features of the study:

This report provides in-depth analysis of the colonoscopy bowel preparation drugs market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2019-2027), considering 2018 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global colonoscopy bowel preparation drugs market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans

Key companies covered as part of this study include Ferring B.V., Bayer AG, Braintree, Bausch Health Companies Inc., and Norgine B.V.

Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, technology upgradation, market expansion, and marketing tactics

The global colonoscopy bowel preparation drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the colonoscopy bowel preparation drugs market

Detailed Segmentation:

  • Global Colonoscopy Bowel Preparation Drugs Market, By Drug Type:
  • Isosmotic Agents
  • High-volume Polyethylene Glycol Preparations
  • Sulfate-free PEG-ELS
  • Low-volume PEG Preparations
  • Hyposmotic Agents
  • Hyperosmotic Agents
  • Oral sodium Sulfate
  • Magnesium Citrate
  • Sodium Phosphate
  • Combination Agents
  • Sodium Picosulfate/Magnesium Citrate
  • Sodium Sulfate and SF-PEG-ELS
  • Global Colonoscopy Bowel Preparation Drugs Market, By Distribution Channel:
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Others
  • Global Colonoscopy Bowel Preparation Drugs Market, By Region:
  • North America
  • By Drug Type:
  • Isosmotic Agents
  • High-volume Polyethylene Glycol Preparations
  • Sulfate-free PEG-ELS
  • Low-volume PEG Preparations
  • Hyposmotic Agents
  • Hyperosmotic Agents
  • Oral sodium Sulfate
  • Magnesium Citrate
  • Sodium Phosphate
  • Combination Agents
  • Sodium Picosulfate/Magnesium Citrate
  • Sodium Sulfate and SF-PEG-ELS
  • By Distribution Channel:
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Others
  • By Country:
  • U.S.
  • Canada
  • Latin America
  • By Drug Type:
  • Isosmotic Agents
  • High-volume Polyethylene Glycol Preparations
  • Sulfate-free PEG-ELS
  • Low-volume PEG Preparations
  • Hyposmotic Agents
  • Hyperosmotic Agents
  • Oral sodium Sulfate
  • Magnesium Citrate
  • Sodium Phosphate
  • Combination Agents
  • Sodium Picosulfate/Magnesium Citrate
  • Sodium Sulfate and SF-PEG-ELS
  • By Distribution Channel:
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Others
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Drug Type:
  • Isosmotic Agents
  • High-volume Polyethylene Glycol Preparations
  • Sulfate-free PEG-ELS
  • Low-volume PEG Preparations
  • Hyposmotic Agents
  • Hyperosmotic Agents
  • Oral sodium Sulfate
  • Magnesium Citrate
  • Sodium Phosphate
  • Combination Agents
  • Sodium Picosulfate/Magnesium Citrate
  • Sodium Sulfate and SF-PEG-ELS
  • By Distribution Channel:
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Others
  • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Drug Type:
  • Isosmotic Agents
  • High-volume Polyethylene Glycol Preparations
  • Sulfate-free PEG-ELS
  • Low-volume PEG Preparations
  • Hyposmotic Agents
  • Hyperosmotic Agents
  • Oral sodium Sulfate
  • Magnesium Citrate
  • Sodium Phosphate
  • Combination Agents
  • Sodium Picosulfate/Magnesium Citrate
  • Sodium Sulfate and SF-PEG-ELS
  • By Distribution Channel:
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Others
  • By Country:
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Drug Type:
  • Isosmotic Agents
  • High-volume Polyethylene Glycol Preparations
  • Sulfate-free PEG-ELS
  • Low-volume PEG Preparations
  • Hyposmotic Agents
  • Hyperosmotic Agents
  • Oral sodium Sulfate
  • Magnesium Citrate
  • Sodium Phosphate
  • Combination Agents
  • Sodium Picosulfate/Magnesium Citrate
  • Sodium Sulfate and SF-PEG-ELS
  • By Distribution Channel:
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Others
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Drug Type:
  • Isosmotic Agents
  • High-volume Polyethylene Glycol Preparations
  • Sulfate-free PEG-ELS
  • Low-volume PEG Preparations
  • Hyposmotic Agents
  • Hyperosmotic Agents
  • Oral sodium Sulfate
  • Magnesium Citrate
  • Sodium Phosphate
  • Combination Agents
  • Sodium Picosulfate/Magnesium Citrate
  • Sodium Sulfate and SF-PEG-ELS
  • By Distribution Channel:
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Others
  • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • Ferring B.V*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Highlights
  • Market Strategies
  • Bayer AG
  • Braintree
  • Bausch Health Companies Inc.
  • Norgine B.V.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug Type
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Regulatory Scenario
  • Reimbursement Scenario
  • Epidemiology
  • PEST Analysis
  • Recent Product Launch
  • Merger and Acquisition Scenario

4. Global Colonoscopy Bowel Preparation Drugs Market, By Drug Type, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Isosmotic Agents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • High-volume Polyethylene Glycol Preparations
    • Sulfate-free PEG-ELS
    • Low-volume PEG Preparations
  • Hyposmotic Agents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Hyperosmotic Agents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Oral sodium Sulfate
    • Magnesium Citrate
    • Sodium Phosphate
  • Combination Agents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Sodium Picosulfate/Magnesium Citrate
    • Sodium Sulfate and SF-PEG-ELS

5. Global Colonoscopy Bowel Preparation Drugs Market, By Distribution Channel, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Colonoscopy Bowel Preparation Drugs Market, By Region, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2027
  • North America
    • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Drug Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2016 - 2027, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

7. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • Ferring B.V.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bayer AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Braintree
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bausch Health Companies Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Norgine B.V.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Analyst Views

8. Section

  • References
  • Research Methodology
  • About Us and Sales Contact